Allakos Inc. (ALLK)

$0.58 6.72% $0.04 Healthcare

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

$51.20M

Dr. Robert Alexander Ph.D.

192.00

Redwood City, CA

Jul 19, 2018

-0.25

$-2.35

0.74

3.57

-1,915.20%

-0.24

0.00

0.59

4.63

3.57

-131.66%

-142.60%

Similar stocks (22)

Revolution Medicines, Inc.

RVMD

$46.18 4.81%
Uptrend

Blueprint Medicines Corporation

BPMC

$90.94 1.80%
Downtrend

Ultragenyx Pharmaceutical Inc.

RARE

$58.78 1.87%
Uptrend

Apellis Pharmaceuticals, Inc.

APLS

$36.73 3.09%
Downtrend

Crinetics Pharmaceuticals, Inc.

CRNX

$53.88 2.10%
Uptrend

Arvinas, Inc.

ARVN

$25.60 2.52%
Downtrend

Kura Oncology, Inc.

KURA

$21.08 4.05%
Neutral

Arcus Biosciences, Inc.

RCUS

$16.80 1.88%
Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$14.32 3.84%
Downtrend

Sana Biotechnology, Inc.

SANA

$4.62 7.69%
Downtrend

Annexon, Inc.

ANNX

$7.02 1.37%
Uptrend

Allogene Therapeutics, Inc.

ALLO

$2.91 1.04%
Downtrend

Fate Therapeutics, Inc.

FATE

$4.00 3.09%
Downtrend

G1 Therapeutics, Inc.

GTHX

$7.15 0.00%
Uptrend

Heron Therapeutics, Inc.

HRTX

$2.02 3.59%
Downtrend

Sangamo Therapeutics, Inc.

SGMO

$0.90 7.51%
Uptrend

Caribou Biosciences, Inc.

CRBU

$2.07 -0.48%
Downtrend

Assembly Biosciences, Inc.

ASMB

$18.50 1.82%
Uptrend

CytomX Therapeutics, Inc.

CTMX

$1.17 -1.68%
Downtrend

Spero Therapeutics, Inc.

SPRO

$1.36 1.12%
Downtrend

Atara Biotherapeutics, Inc.

ATRA

$7.93 0.76%
Downtrend

NextCure, Inc.

NXTC

$1.43 2.14%
Downtrend

ETF Exposure (15)

John Hancock Multifactor Small Cap ETF

JHSC

0.18%

$40.11 1.85%
Uptrend

iShares Micro-Cap ETF

IWC

0.01427%

$126.54 2.19%
Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0%

$71.02 2.33%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Quantitative Funds - Vanguard Growth and Income Fund

VGIAX

0%

$108.92 1.76%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Growth and Income Fund

VQNPX

0%

$66.74 1.75%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend